New research from UK-based powder characterisation specialist Freeman Technology uses the company’s FT4 powder rheometer to explore the application of dynamic powder testing in assessing the impact of humidity on powder flow.
Members of the Freeman Technology team will be available on the company’s stand at Powtech 2011, which takes place between 11–13 October, in Nürnberg, Germany, to discuss their findings and to demonstrate the FT4 powder rheometer.
The company says the research would be of particular interest to manufacturers working to improve their ability to control and more effectively manage this aspect of powder processing. It indicates that moisture adsorbed from the environment can have a range of effects, depending on the powder type, whether hydrophobic or hydrophilic, and the results challenge the simplistic conclusion that all adsorbed moisture is detrimental to powder flow.
The work also shows that under conditions of either low or extremely high humidity the impact of moisture on powder flow properties is not linear.
The conclusion is that no single powder property precisely captures the effects of humidity but that measurement and analysis of a combination of bulk and dynamic powder properties provides a degree of insight.
To find out more about these humidity studies, to learn more about dynamic powder characterisation, or to see the FT4 Powder Rheometer in action, visit the Freeman Technology stand at Powtech Hall 6-444.
Freeman will discuss effect of humidity on powders at Powtech 2011
UK firm has carried out research using the FT4 powder rheometer
You may also like
Trending Articles
You may also like
Manufacturing
![SCHOTT Pharma launches EVERIC lyo & amber vials for light-sensitive ADCs]()
SCHOTT Pharma launches EVERIC lyo & amber vials for light-sensitive ADCs
Featuring the well-known EVERIC® lyo coating, EVERIC® lyo & amber is designed for lyophilised, light-sensitive antibody-drug-conjugates (ADCs). It offers reliable light protection at the primary packaging level, already during the fill-and-finish process. EVERIC amber is the first specialty vial for highly light-sensitive medications that simultaneously meets regulatory light transmission requirements in the EU, the U.S., and Japan
You need to be a subscriber to read this article.
Click here to find out more.
Click here to find out more.
Manufacturing
![Portable gas detection in the pharmaceutical sector]()
Portable gas detection in the pharmaceutical sector
Gas safety is a critical consideration in the pharmaceutical sector. Hazardous gases and airborne contaminants are common by-products of manufacturing processes … and employers must control worker exposure in accordance with relevant legislation and industry standards
Manufacturing
![New legal duties for QPs in decentralised manufacturing]()
New legal duties for QPs in decentralised manufacturing
In this clip, Dr. Peter Gough explains that QPs will be responsible for supervising decentralised activities, conducting regular audits, carrying out periodic on-site visits, confirming GMP compliance to regulatory authorities and notifying changes that may affect quality or safety
Manufacturing
![FDA escalates action against Dabur India over systemic data-integrity and cGMP failures]()
FDA escalates action against Dabur India over systemic data-integrity and cGMP failures
The US FDA has issued a warning letter to Dabur India following an inspection that identified falsified records, missing laboratory data, inadequate cleaning and process validation and weaknesses in quality-unit oversight, saying the company's response failed to address the systemic nature of the deficiencies
Manufacturing
![DNA Script and GE Healthcare awarded $26m ARPA-H funding to scale cell-free DNA bioproduction]()
DNA Script and GE Healthcare awarded $26m ARPA-H funding to scale cell-free DNA bioproduction
The pair will combine DNA Script's EDS technology with GE HealthCare's DNA scaling technology to create a faster, more flexible manufacturing process for cell-free DNA as the use of personalised and time-sensitive genetic medicines grows
